uniQure NV 2023 SR
The report outlines uniQure's 2023 corporate responsibility initiatives across five core pillars: Community Outreach, Diversity Equity & Inclusion, Employee Wellness and Engagement, Corporate Governance, and Environmental Impact. Key highlights include the Best Product award for HEMGENIX at the Prix Galien USA Gala and significant pipeline progress in gene therapies for Huntington's disease, epilepsy, and Fabry disease. The company achieved a 100% renewable electricity rate and launched the uniQares platform, which saw high employee engagement in community service and environmental challenges. Additionally, uniQure emphasized its commitment to diversity, reporting a workforce that is 54% female and represents over 60 nations.
Company: uniQure NV
Sector: Health Care
Country: Netherlands
Year: 2023
Type: SR
Pages: 11
uniQure NV
The report outlines uniQure's 2023 corporate responsibility initiatives across five core pillars: Community Outreach, Diversity Equity & Inclusion, Employee Wellness and Engagement, Corporate Governance, and Environmental Impact. Key highlights include the Best Product award for HEMGENIX at the Prix Galien USA Gala and significant pipeline progress in gene therapies for Huntington's disease, epilepsy, and Fabry disease. The company achieved a 100% renewable electricity rate and launched the uniQares platform, which saw high employee engagement in community service and environmental challenges. Additionally, uniQure emphasized its commitment to diversity, reporting a workforce that is 54% female and represents over 60 nations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Employees